Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference
BEDFORD, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and CEO of Anika, will present at the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego on Monday, March 10, 2025 at 2:30pm PT / 5:30pm ET. Management will also participate in one-on-one investor meetings throughout the event.
The presentation will be webcast live on the Events and Webcasts page under the Investors section of Anika Therapeutics' website and will be archived for 30 days following the presentation. For more information about this event or to schedule a one-on-one meeting with Anika's senior management, please contact Anika's Investor Relations at investorrelations@anika.com.
About AnikaAnika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management and Regenerative Solutions, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika's global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.
ANIKA, ANIKA THERAPEUTICS, CINGAL, HYALOFAST, INTEGRITY, MONOVISC, ORTHOVISC, TACTOSET, and the Anika logo are trademarks of Anika Therapeutics, Inc. or its subsidiaries or are licensed to Anika Therapeutics, Inc. for its use.
For Investor Inquiries:Anika Therapeutics, Inc.Matt Hall, 781-457-9554Director, Corporate Development and Investor Relationsinvestorrelations@anika.comSign in to access your portfolio
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
HubSpot, Inc. (HUBS): A Bull Case Theory
We came across a bullish thesis on HubSpot, Inc. (HUBS) on Compouding Your Wealth's Substack. In this article, we will summarize the bulls' thesis on HUBS. HubSpot, Inc. (HUBS)'s share was trading at $578.25 as of 29th May. HUBS's forward P/E was 61.73 according to Yahoo Finance. A person using a laptop with a blue background showing the software platform's user inteface. HubSpot reported strong financial results for Q1 2025, with revenue reaching $714.1 million, a 15.7% increase year-over-year and 20.8% quarter-over-quarter growth, surpassing estimates by 2.3%. Subscription revenue, which makes up nearly 98% of total revenue, grew by the same rate, highlighting continued customer demand for its core offerings. While gross margin declined slightly by 0.7 percentage points to 83.9%, and operating margin dropped by 0.9 points to 14%, free cash flow margin improved modestly to 17.1%. Net margin was negative 3.1%, reflecting a 4-point decrease from the prior year, largely influenced by non-GAAP adjustments and timing of certain expenses. Earnings per share of $1.78 exceeded expectations by 1.7%. Key metrics such as deferred revenue and remaining performance obligations showed significant growth, up nearly 20% and 37% respectively, underscoring strong future revenue visibility. Billings rose by 19.6%, though average revenue per customer declined slightly by 3.6%, signaling some pressure on pricing or customer mix. Customer count increased by 19.1% to over 258,000. On the operational side, sales and marketing efficiency improved with S&M expense as a percentage of revenue falling by 1.6 points, while R&D and G&A expenses rose modestly as a share of revenue. The company highlighted its rapid product innovation with over 200 new features released, particularly embedding AI across its platform and expanding enterprise capabilities. AI-powered tools like Customer Agent have driven measurable improvements in sales and support efficiency. HubSpot raised its full-year revenue guidance to approximately $3.04 billion, projecting continued growth fueled by a combination of seat expansion and consumption-based AI monetization, while maintaining a cautious view on macroeconomic uncertainty. For a comprehensive analysis of another standout stock covered by the same author, we recommend reading our summary of this bullish thesis on Shopify Inc. (SHOP). HubSpot, Inc. (HUBS) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 61 hedge fund portfolios held HUBS at the end of the first quarter which was 73 in the previous quarter. While we acknowledge the potential of HUBS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
22 minutes ago
- Yahoo
Wedding Expert Jessica Bishop to Host Free Virtual Savvy Weddings Summit
Murfreesboro, TN, June 06, 2025 (GLOBE NEWSWIRE) -- Murfreesboro, TN. – Jessica Bishop, a nationally recognized wedding expert and founder of The Budget Savvy Bride, is hosting a free virtual wedding summit on June 21-22, designed to help engaged couples confidently plan a wedding that reflects their values — without overspending or unnecessary stress. At a time when wedding planning can often feel overwhelming and financially daunting, The Savvy Weddings Summit aims to simplify the process and empower couples with accessible, expert-led guidance. From navigating budgets and managing logistics to creating a celebration that is both meaningful and manageable, the summit delivers practical, actionable advice — not just pretty inspiration. 'So many couples feel pressured to create a 'Pinterest-perfect' wedding they can't afford, or they simply don't know where to start,' said Bishop. 'This summit is about giving couples the tools and confidence to plan intentionally, in alignment with their priorities — not the industry's expectations.' Bishop, a seasoned voice in the wedding industry, created the summit to democratize access to expert advice, ensuring that couples can achieve their ideal celebration regardless of their budget constraints. Attendees of The Savvy Weddings Summit will gain valuable insights into various aspects of wedding planning, from smart budgeting strategies to vendor selection, decor, and timeline management. The expert-led sessions are curated to provide actionable advice that couples can immediately apply to their planning process. All registered attendees will also receive access to a virtual goodie bag with exclusive discounts from various wedding brands, including summit sponsors Miss to Mrs Box and Something Borrowed Blooms. As an added incentive, all attendees who register for the free virtual summit will be entered to win prizes, including a dream honeymoon! This grand prize package includes airfare credit and ground transportation, offering a significant opportunity for a newlywed couple to celebrate their marriage in paradise! Register today for your chance to win a dream honeymoon to Mexico! Enter now at for a chance to win the grand prize: a 4-night Island Reserve Inclusive® stay for two adults at Margaritaville Island Reserve Riviera Maya, including round-trip Airfare credit (up to $500 per person) and airport from Jessica Bishop Jessica Bishop founded The Budget Savvy Bride with the mission to prove that beautiful, meaningful weddings are achievable on any budget. Her platform has become a trusted resource for millions of couples seeking practical advice and inspiration for affordable wedding planning. The Savvy Weddings Summit is a direct extension of this mission, bringing together a community of experts to support couples on their journey, democratizing access to expert advice, especially for couples who may not have the budget for a full-service wedding planner. The virtual format of the summit ensures accessibility for couples nationwide, allowing them to participate from the comfort of their homes. This flexible approach caters to busy schedules, making expert wedding planning advice more attainable. Couples interested in planning their dream wedding without financial strain are encouraged to register for the free virtual Savvy Weddings Summit. Detailed information about the summit, including the full schedule of sessions, speaker lineup, and registration details for the Mexico honeymoon giveaway, is available at About The Budget Savvy BrideJessica Bishop is a budget wedding expert, a best-selling author, and the founder of The Budget Savvy Bride, an extensive online resource to help couples plan a beautiful wedding on a budget they can actually afford. Jessica has shared her money-saving tips and planning advice with outlets such as The New York Times, Washington Post, GMA, BRIDES, Refinery 29, Glamour, Cosmopolitan, Huffington Post, and more. Jessica is also the host of The Bouquet Toss: Wedding Planning Podcast. Her book, The Budget-Savvy Wedding Planner & Organizer, is an Amazon best-seller, with over 250,000 copies sold! CONTACT: Heather Holmes heather@ 1+(828)332-5307
Yahoo
26 minutes ago
- Yahoo
Keros Therapeutics Announces Participation at Goldman Sachs 46th Annual Global Healthcare Conference
LEXINGTON, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. ('Keros') (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta ('TGF-ß') family of proteins, today announced that Keros' Chair and Chief Executive Officer Jasbir S. Seehra, Ph.D., will participate in a fireside chat presentation at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025 at 9:20 a.m. Eastern time. A live audio webcast of the fireside chat presentation will be available at and an archived replay will be accessible in the Investors section of the Keros website at for up to 90 days following the conclusion of the event. About Keros Therapeutics, is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the TGF-ß family of proteins. Keros is a leader in understanding the role of the TGF-ß family of proteins, which are master regulators of the growth, repair and maintenance of a number of tissues, including blood, bone, skeletal muscle, adipose and heart tissue. By leveraging this understanding, Keros has discovered and is developing protein therapeutics that have the potential to provide meaningful and potentially disease-modifying benefit to patients. Keros' lead product candidate, KER-065, is being developed for the treatment of neuromuscular diseases, with an initial focus on Duchenne muscular dystrophy. Keros' most advanced product candidate, elritercept (KER-050), is being developed for the treatment of cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndrome and in patients with myelofibrosis. Investor Contact:Justin Frantzjfrantz@ 617-221-6042 Media Contact:Mahmoud Siddig / Adam Pollack / Viveca TressJoele Frank, Wilkinson Brimmer Katcher(212) 355-4449Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data